DCIS was detected on pre-NAC biopsy in 46 of the patients who achieved (16.3%), distributed as follows: 7 luminal BCs (21.9%), 10 TNBC s (7.1%) and 29 HER2-positive BCs (26.4%). The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.